Technical Data
Epstein Barr Virus, Early Antigen (EBV, Human Herpes virus 4, HHV4)
EBV early antigen is the first detectable marker of EBV infection in human cells

Suitable for use in Immunofluorescence and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
Immunohistochemistry: paraffin sections
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
MabIgG110C121Affinity Purified
200ug-20CBlue IceMouse
Affinity purified early antigen polypeptides precipitated from African Burkitt's Lymphoma.
Purified by Protein A affinity chromatography.
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Recognizes the the p50:p55 polypeptide complex associated with the early antigen of Epstein-Barr virus (EBV). Produces an intense diffuse and speckled staining pattern detectable in the nucleus of paraformaldehyde/acetone fixed cells expressing the EBV early nuclear antigen. Acetone and methanol fixation can be used, but the results are a less bright, coarsely granular nuclear staining pattern.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Epstein, A.L. et al. (1984) Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells. J. Virol. 50: 372-379.